# Partially HLA-Matched Irradiated Allogeneic Cellular Therapy After Reduced Intensity Total Body Irradiation

> **NCT00996359** · PHASE1 · TERMINATED · sponsor: **University of Medicine and Dentistry of New Jersey** · enrollment: 4 (actual)

## Conditions studied

- Leukemia
- Lymphoma
- Multiple Myeloma and Plasma Cell Neoplasm
- Myelodysplastic Syndromes

## Interventions

- **BIOLOGICAL:** Irradiated haploidentical allogeneic lymphocytes
- **RADIATION:** total-body irradiation

## Key facts

- **NCT ID:** NCT00996359
- **Lead sponsor:** University of Medicine and Dentistry of New Jersey
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-10
- **Primary completion:** 2011-11
- **Final completion:** 2011-11
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Slow accrual
- **Last updated:** 2013-09-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00996359

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00996359, "Partially HLA-Matched Irradiated Allogeneic Cellular Therapy After Reduced Intensity Total Body Irradiation". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00996359. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*